Literature DB >> 21842108

Risk assessment and follow-up are the keys to preventing severe hyperbilirubinemia.

M Jeffrey Maisels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21842108     DOI： 10.2223/JPED.2120

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN： 0021-7557            Impact factor:   2.197


× No keyword cloud information.
  3 in total

1.  Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population.

Authors:  Chalirmporn Atasilp; Janjira Kanjanapipak; Jaratdao Vichayaprasertkul; Pimonpan Jinda; Rawiporn Tiyasirichokchai; Pornpen Srisawasdi; Chatchay Prempunpong; Monpat Chamnanphon; Apichaya Puangpetch; Natchaya Vanwong; Suwit Klongthalay; Thawinee Jantararoungtong; Chonlaphat Sukasem
Journal:  BMC Pediatr       Date:  2022-05-02       Impact factor: 2.567

2.  Polymorphic variants of SLCO1B1 in neonatal hyperbilirubinemia in China.

Authors:  Jiebo Liu; Jun Long; Shaofang Zhang; Xiaoyan Fang; Yuyuan Luo
Journal:  Ital J Pediatr       Date:  2013-08-12       Impact factor: 2.638

3.  UGT1A1 mutation association with increased bilirubin levels and severity of unconjugated hyperbilirubinemia in ABO incompatible newborns of China.

Authors:  Hui Yang; Fen Lin; Zi-Kai Chen; Lin Zhang; Jia-Xin Xu; Yong-Hao Wu; Jing-Ying Gu; Yu-Bin Ma; Jian-Dong Li; Li-Ye Yang
Journal:  BMC Pediatr       Date:  2021-06-01       Impact factor: 2.125
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.